Impact BioMedical Current Cash

Impact BioMedical (IBO) currently reports a current cash of $10K as of June 2026. That compares with $620K in the prior-year period — down 98.4% year over year. Use the charts on this page to explore Impact BioMedical's current cash history and peer comparisons.

Impact BioMedical's current cash decreased from $620K to $10K — a 98.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Impact BioMedical reported $10K in current cash as of June 2026. That compares with $620K in the prior-year period — down 98.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $10K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Impact BioMedical, and consider following IBO for alerts when major investors trade the stock.

Impact BioMedical is classified in the Healthcare sector. On current cash, it currently shows $10K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IBO with unrelated industries.